RESUMO
BACKGROUND: Many drugs are prescribed in relieving acute migraine attacks, we aim to compare metoclopramide with other antimigraine drugs. METHODS: We searched online databases like PubMed, Cochrane Library, Scopus, and Web of Science till June 2022 for RCTs that compared metoclopramide alone with placebo or active drugs. The main outcomes were the mean change in headache score and complete headache relief. The secondary outcomes were the rescue medications need, side effects, nausea and recurrence rate. We qualitatively reviewed the outcomes. Then, we performed the network meta-analyses (NMAs) when it was possible. which were done by the Frequentist method using the MetaInsight online software. RESULTS: Sixteen studies were included with a total of 1934 patients: 826 received metoclopramide, 302 received placebo, and 806 received other active drugs. Metoclopramide was effective in reducing headache outcomes even for 24 h. The intravenous route was the most chosen route in the included studies and showed significant positive results regarding headache outcomes; however, the best route whether intramuscular, intravenous, or suppository was not compared in the previous studies. Also, both 10 and 20 mg doses of metoclopramide were effective in improving headache outcomes; however, there was no direct comparison between both doses and the 10 mg dose was the most frequently used dosage. In NMA of headache change after 30 min or 1 h, metoclopramide effect came after granisetron, ketorolac, chlorpromazine, and Dexketoprofen trometamol. Only granisetron's effect was significantly higher than metoclopramide's effect which was only significantly higher than placebo and sumatriptan. In headache-free symptoms, only prochlorperazine was non-significantly higher than metoclopramide which was higher than other medications and showed significantly higher effects only with placebo. In rescue medication, metoclopramide's effect was only non-significantly lower than prochlorperazine and chlorpromazine while its effect was higher than other drugs and showed higher significant effects only than placebo and valproate. In the recurrence rate, studies showed no significant difference between metoclopramide and other drugs. Metoclopramide significantly decreased nausea more than the placebo. Regarding side effects, metoclopramide showed a lower incidence of mild side effects than pethidine and chlorpromazine and showed a higher incidence of mild side effects than placebo, dexamethasone, and ketorolac. The reported extrapyramidal symptoms with metoclopramide were dystonia or akathisia. CONCLUSION: A dose of 10 mg IV Metoclopramide was effective in relieving migraine attacks with minimal side effects. Compared to other active drugs, it only showed a lower significant effect compared with granisetron regarding headache change while it showed significantly higher effects only with placebo in both rescue medication needs and headache-free symptoms and valproate in only rescue medication need. Also, it significantly decreased headache scores more than placebo and sumatriptan. However, more studies are needed to support our results.
Assuntos
Metoclopramida , Transtornos de Enxaqueca , Humanos , Metoclopramida/efeitos adversos , Sumatriptana/uso terapêutico , Metanálise em Rede , Proclorperazina/efeitos adversos , Clorpromazina/uso terapêutico , Granisetron/uso terapêutico , Ácido Valproico/uso terapêutico , Cetorolaco/uso terapêutico , Ensaios Clínicos Controlados Aleatórios como Assunto , Transtornos de Enxaqueca/tratamento farmacológico , Transtornos de Enxaqueca/complicações , Náusea/induzido quimicamente , Náusea/tratamento farmacológico , Cefaleia/complicaçõesRESUMO
Achieving low-energy-barrier lithium ion transport is a fundamental issue for composite solid-state electrolytes (CSEs) in all-solid-state lithium metal batteries (ASSLMBs). In this work, a hydrogen bonding induced confinement strategy was proposed to construct confined template channels for low-energy-barrier lithium ion continuous transport. Specifically, the ultrafine boehmite nanowires (BNWs) with 3.7 nm diameter were synthesized and superiorly dispersed in a polymer matrix to form a flexible CSE. The ultrafine BNWs with large specific surface areas and abundant oxygen vacancies assist the dissociation of lithium salts and confine the conformation of polymer chain segments by hydrogen bonding between the BNWs and the polymer matrix, thus forming a polymer/ultrafine nanowire intertwined structure as template channels for dissociated lithium ions continuous transport. As a result, the as-prepared electrolytes displayed a satisfactory ionic conductivity of 0.714 mS cm-1 and low energy barrier (16.30 kJ mol-1), and the assembled ASSLMB delivered excellent specific capacity retention (92.8%) after 500 cycles. This work demonstrates a promising way to design CSEs with high ionic conductivity for high-performance ASSLMBs.
RESUMO
Chest pain in pediatric patients is a common concern in pediatric emergency departments (ED). In most cases, benign conditions are related to noncardiac causes, and only a minority of the cases are caused by heart disease. This research aimed to evaluate the causes and characteristics of chest pain among children in a pediatric emergency department. This retrospective study evaluated children younger than 14 years of age who presented to the emergency department of a general pediatric hospital in the Eastern area of Saudi Arabia with non-traumatic chest pain between 2017 and 2022. The data included socioeconomic information, physical examination findings, and the results of basic investigations, such as chest X-ray and electrocardiogram. The Chi-square test was performed to compare various etiologies, with a 5% significant level. The study evaluated 310 patients with a mean age of 9.1±2.7 years. The majority of children presenting with chest pain had normal physical examinations, except 3.3% who showed respiratory and cardiac findings. The diagnostic tests indicated pneumonia in 2.9% and arrhythmia in 2.1% of children. Most patients were discharged with a diagnosis of idiopathic or muscular chest pain. The majority of patients (95%) were treated symptomatically in outpatient settings, with just one patient requiring hospitalization. The most common cause of chest pain prompting a child to visit the ED was idiopathic chest pain. Therefore, this study highlights the significance of obtaining a comprehensive medical history and physical examination to reveal important clues and help avoid unnecessary tests.
Assuntos
Dor no Peito , Serviço Hospitalar de Emergência , Humanos , Criança , Estudos Retrospectivos , Dor no Peito/diagnóstico , Dor no Peito/epidemiologia , Dor no Peito/etiologia , Hospitalização , Eletrocardiografia/efeitos adversosRESUMO
Rectal perforations during pelvic surgery are rare but serious complications. The occurrence of rectal involvement is generally lower than that of the involvement of other portions of the bowel. The urologic field is responsible for the majority of iatrogenic rectal injuries from pelvic surgery; general and gynecologic surgeries are prone to the occurrence as well, the latter especially in the case of rectal shaving for deep infiltrating endometriosis. Attention should be posed to the prevention of rectal injuries, especially in case of challenging or salvage procedures; some tricks may be recommended to avoid thermal and mechanical damages and to realize a safe dissection. Intraoperative detection of rectal injuries is of paramount importance; once confirmed, immediate management with the closure of the defect is recommended. In general, rectal injuries diagnosed after surgery are liable to significantly worse outcomes than those detected and managed intraoperatively. Patient summary: Rectal perforation is a rare but possible complication of pelvic surgeries. The more challenging the procedure (ie, surgery for locally advanced tumors or after radiation therapy), the higher the risk of rectal lesion. Intraoperative management of the injury should be attempted, with direct repair of the defect with or without fecal diversion.
RESUMO
Solid-state lithium-ion batteries with high safety are the encouraging next-generation rechargeable electrochemical energy storage devices. Yet, low Li+ conductivity of solid electrolyte and instability of solid-solid interface are the key issues hampering the practicability of the solid electrolyte. In this research, core-shell MOF-in-MOF nanopores UIO-66@67 are proposed as a unique bifunctional host of ionic liquid (IL) to fabricate core-shell ionic liquid-solid electrolyte (CSIL). In the current design of CSIL, the shell structure (UIO-67) has a large pore size and a high specific surface area, boosting the absorption amount of ionic liquid electrolyte, thus increasing the ionic conductivity. Nevertheless, the core structure (UIO-66) has a small pore size compared to the ionic liquid, which can confine the large ions, decreasing their mobility, and selectively boost the transport of Li+ . The CSIL solid electrolyte exhibits considerable enhancement in the lithium transference number (tLi + ) and ionic conductivity compared to the homogenous porous host (pure UIO-66 and UIO-67). Additionally, the Li|CSIL|Li symmetric batteries maintain a stable polarization of less than 28 mV for more than 1000 h at 1000 µA cm-2 . Overall, the results demonstrate the concept of core-shell MOF-in-MOF nanopores as a promising bifunctional host of electrolytes for solid-state or quasi-solid-state rechargeable batteries.
RESUMO
BACKGROUND: The main purpose is to investigate the effect of LiCO3 as an add-on therapy with radioactive iodine in increasing the cure and decreasing the T4 level compared to radioactive iodine alone. The primary outcome is the cure rate as defined by the number of hyperthyroid patients who became euthyroid or hypothyroid. The secondary outcome is the T4 level. METHODS: Four databases were searched (PubMed, Scopus, Web of Science, and Cochrane central library). The inclusion criteria were randomized and non-randomized clinical trials of hyperthyroidism patients receiving LiCO3 with radioiodine compared with hyperthyroidism patients receiving radioactive iodine alone. Included studies were appraised with the risk of bias version 2 tool, according to the Cochrane Handbook for Systematic Reviews of Interventions 5.1.0. RESULTS: Nine studies were eligible for inclusion in the study, six randomized control trials and three non-randomized control trials. There were 477 patients in the intervention group and 451 patients in the control group. The cure rate was not significantly different between the two groups, while it was significantly increased with 5000 to 6500 mg optimized cumulative dose of LiCO3 compared with the control group, P = 0.0001. The T4 level showed no significant difference between the two groups, P = 0.13. CONCLUSIONS: LiCO3 adjunct to radioactive iodine did not show significant differences compared with radioactive iodine alone in terms of cure rate or decreasing T4 level. However, the dose of 5000 to 6000 mg of LiCO3 may increase the cure rate.